Pfizer (PFE) Tops Q2 EPS by 1c, Updates FY EPS Guidance
Tweet
Share
E-mail
Get Alerts PFE Hot Sheet
Price: $27.66 +0.07%
EPS Growth %: -12.6%
Financial Fact:
Diluted (in shares): 6.14B
Today's EPS Names:
VIVO, OCCI, ALZN, More
EPS Growth %: -12.6%
Financial Fact:
Diluted (in shares): 6.14B
Today's EPS Names:
VIVO, OCCI, ALZN, More
Join SI Premium – FREE
Pfizer (NYSE: PFE) reported Q2 EPS of $0.67, $0.01 better than the analyst estimate of $0.66. Revenue for the quarter came in at $12.9 billion versus the consensus estimate of $13.08 billion.
GUIDANCE:
Pfizer sees FY2017 EPS of $2.54-$2.60, versus the consensus of $2.55. Pfizer sees FY2017 revenue of $52-54 billion.
For earnings history and earnings-related data on Pfizer (PFE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Westinghouse said to seek over $50 billion valuation in planned IPO
- Barclays says AI trade is maturing, favors greater diversification
- Faraday Future unveils nine robot models, prices start at $9,990
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
